期刊
NANO TODAY
卷 25, 期 -, 页码 135-155出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2019.02.012
关键词
Silicon; Black phosphorus; Nanomedicine; Biocompatible; Biodegradable
资金
- National Natural Science Foundation of China (NSFC) [61435010, 61875138]
- Science and Technology Innovation Commission of Shenzhen [JCYJ20170818093453105]
- China Postdoctoral Science Foundation [2017M610540, 20181110892]
- PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China [2018A030310500]
- PhD Fund of Natural Science Foundation of Shandong Province, China [ZR2016BB33]
- MEPhI Academic Excellence Project [02.a03.21.0005]
Nanomedicine has made great progress toward the diagnosis and treatment of diseases by exploiting physicochemical properties and biological interactions of nanomaterials that differ from the corresponding conventional materials. In the past decade, the advancement of biocompatible and biodegradable inorganic nanostructures has produced numerous nanomedicine platforms. Silicon and, more recently, black phosphorus (BP) offer promising nanoplatforms for bio-applications, including bioimaging, photo therapy, drug delivery, combination therapy, and theranostics, due to their intrinsic unique properties, negligible elemental cytotoxicity, high drug-loading potential, long blood circulation time, and specific clearance pathways. In view of the growing importance of silicon and BP nanomaterials in the progress of nanomedicine, and their common feature characteristics as biodegradable biocompatible elemental semiconductors, this contribution reviews the latest advances in silicon and BP-based biomedical nanomaterials for disease diagnosis and therapy. (C) 2019 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据